Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
TAILSTORM HEALTH
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class I - Dangerous
Lack of Sterility Assurance
Subpotent Drug: reduced efficacy for epinephrine